Franklin, Andrews, Kramer & Edelstein Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Franklin, Andrews, Kramer & Edelstein

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scion who wrote (12525)	1/29/2021 3:08:50 PM
From: scion	Read Replies (2) of 12881

Live Coronavirus latest news: Single-dose Johnson & Johnson vaccine 100pc effective at preventing deaths, hospitalisations telegraph.co.uk A single-dose vaccine, made by the US company Johnson & Johnson, is 100 per cent effective at preventing deaths and hospitalisations from Covid-19. This means that one month after vaccination, no one who received the vaccine was admitted to hospital or died, regardless of which strain of coronavirus they were exposed to. In the 44,000-person trial by the company's subsidiary Janssen, based in the Netherlands, they also found the vaccine prevented 66 per cent of moderate to severe cases of Covid-19. The UK has ordered 30m doses of the Janssen vaccine. The jab worked across multiple variants of coronavirus, including the South African variant which has been worrying scientists, the firm said. Responding to the news about the successful trial of the Johnson & Johnson vaccine, Health Secretary Matt Hancock tweeted: "This is yet more good news from Janssen on vaccines. If this jab is approved this could significantly bolster our vaccination programme, especially as a single-dose vaccine." Follow the latest updates below telegraph.co.uk

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next